Vivos Therapeutics (VVOS) Q2 2025 Earnings

May 15Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-1.63
-1.22
-0.81
-0.4

Details

Expected EPS
-0.4
Actual EPS
-0.45
Surprise EPS
-0.05
Surprise Percent
-12.5%

Description

⁨Vivos Therapeutics⁩ (⁦VVOS⁩) has reported earnings of ⁦-0.45⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts